Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04610346 · ClinicalTrials.gov registry record · NA

Assessing an Animal-Assisted Treatment Program for Adults With Aphasia: The Persons With Aphasia Training Dogs Program

A NA study, sponsored by Albert Einstein Healthcare Network.

Completed
Registry status
NA
Development phase
17
Enrollment target

NCT04610346 is a NA study that has completed, run by Albert Einstein Healthcare Network. The registered enrollment target is 17 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04610346, a NA study, has completed, sponsored by Albert Einstein Healthcare Network.

COMPLETED
Registry status
NA
Development phase
17 participants
Enrollment target

Study Summary

The lives of more than 2 million Americans are affected by aphasia, an acquired language impairment most commonly resulting from stroke that affects the ability to remember and express words. The well-being of these individuals is affected not just by the loss of words that is aphasia, but also the loss of friendships and opportunities for community engagement in which the loss of words can result. This study evaluates an animal-assisted treatment, The Persons with Aphasia Training Dogs (PATD) Program, designed to target the psychosocial consequences of aphasia by training participants in positive reinforcement dog training techniques that harness new skill learning and the advantages of interaction with family- or shelter-dwelling dogs to increase confidence and social engagement to support participants in living well with aphasia.

Interventions

  • BEHAVIORAL Persons with Aphasia Training Dogs Program

Trial Details

FieldValue
Enrollment Target 17 participants
Start Date 2023-03-30
Est. Completion 2024-08-28
Phase NA

Sponsor

Albert Einstein Healthcare Network

48 total trials

What the Registry Record Tells You About NCT04610346

The ClinicalTrials.gov registry entry for NCT04610346 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Albert Einstein Healthcare Network, which has 48 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Persons with Aphasia Training Dogs Program is the first listed.

NCT04610346 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04610346 about?

NCT04610346 is a clinical study titled "Assessing an Animal-Assisted Treatment Program for Adults With Aphasia: The Persons With Aphasia Training Dogs Program". The lives of more than 2 million Americans are affected by aphasia, an acquired language impairment most commonly resulting from stroke that affects the ability to remember and express words. The well-being of these individuals is affected not just by the loss of words that is aphasia, but also the ...

What is the current status of trial NCT04610346?

This trial is currently completed. It is a NA study. The enrollment target is 17 participants. The study started on 2023-03-30. Estimated completion is 2024-08-28.

What interventions are being tested in trial NCT04610346?

The interventions under investigation include: Persons with Aphasia Training Dogs Program (BEHAVIORAL).

Who is sponsoring clinical trial NCT04610346?

This trial is sponsored by Albert Einstein Healthcare Network, which has 48 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.